Circulating T follicular helper cells with increased function during chronic graft-versus-host disease-Reference-Cited by-同舟云学术

Circulating T follicular helper cells with increased function during chronic graft-versus-host disease

Published:2016-05-19 Issue:20 Volume:127 Page:2489-2497
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Forcade Edouard¹²³,Kim Haesook T.⁴⁵,Cutler Corey¹²,Wang Kathy¹²,Alho Ana C.¹²,Nikiforow Sarah¹²,Ho Vincent T.¹²,Koreth John¹²,Armand Philippe¹²,Alyea Edwin P.¹²,Blazar Bruce R.⁶,Soiffer Robert J.¹²,Antin Joseph H.¹²,Ritz Jerome¹²⁷

Affiliation:

1. Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;

2. Harvard Medical School, Boston, MA;

3. UMR CNRS 5164, Bordeaux University, Bordeaux, France;

4. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA;

5. Harvard School of Public Health, Boston, MA;

6. Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN; and

7. Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA

Abstract

Key Points cTFH are activated and skewed toward a Th2/Th17 phenotype promoting their B-cell help function during cGVHD. cTFH activation signature correlates with memory B-cell and plasmablast phenotype in cGVHD patients.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/127/20/2489/1393266/2489.pdf

Reference47 articles.

1. Current issues in chronic graft-versus-host disease.;Socié;Blood,2014

2. Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303.;Devine;Biol Blood Marrow Transplant,2011

3. Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.;Soiffer;Blood,2011

4. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.;Sarantopoulos;Blood,2009

5. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.;Kuzmina;Blood,2013

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complex interactions of cellular players in chronic Graft-versus-Host Disease;Frontiers in Immunology;2023-06-26

2. Recent advances and research progress in biomarkers for chronic graft versus host disease;Critical Reviews in Oncology/Hematology;2023-06

3. Hematopoietic stem cell–derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide;JCI Insight;2023-04-24

4. Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice;International Immunopharmacology;2023-04

5. Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host disease;Blood;2023-03-02